Meta-Analysis of Atopic Dermatitis Drugs Favors Two JAK Inhibitors

(MedPage Today) -- Small but statistically significant differences in the safety and efficacy of atopic dermatitis therapies emerged from a systematic review and network meta-analysis of available immunomodulatory options. Using dupilumab (Dupixent...
Source: MedPage Today Dermatology - Category: Dermatology Source Type: news